Design and Synthesis of (<i>Z</i>)-5-(Substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one Analogues as Anti-Tyrosinase and Antioxidant Compounds: In Vitro and In Silico Insights
Jeongin Ko,
Jieun Lee,
Hee Jin Jung,
Sultan Ullah,
Yeongmu Jeong,
Sojeong Hong,
Min Kyung Kang,
Yu Jung Park,
YeJi Hwang,
Dongwan Kang,
Yujin Park,
Pusoon Chun,
Jin-Wook Yoo,
Hae Young Chung,
Hyung Ryong Moon
Affiliations
Jeongin Ko
Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Jieun Lee
Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Hee Jin Jung
Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Sultan Ullah
Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL 33458, USA
Yeongmu Jeong
Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Sojeong Hong
Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Min Kyung Kang
Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Yu Jung Park
Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
YeJi Hwang
Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Dongwan Kang
New Drug Development Center, Department of Medicinal Chemistry, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea
Yujin Park
New Drug Development Center, Department of Medicinal Chemistry, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea
Pusoon Chun
College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Korea
Jin-Wook Yoo
Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Hae Young Chung
Department of Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Hyung Ryong Moon
Department of Manufacturing Pharmacy, College of Pharmacy, Pusan National University, Busan 46241, Korea
Many compounds containing the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, including cinnamamide derivatives, have been shown to inhibit tyrosinase potently in vitro and in vivo. Structural changes to cinnamamide derivatives were produced by adding a dithionate functional group to provide eight (Z)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs with high log p values for skin. These analogs were synthesized using a two-step reaction, and their stereochemistry was confirmed using the 3JC4-Hβ values of C4 measured in proton-coupled 13C mode. Analogs 2 (IC50 = 5.21 ± 0.86 µM) and 3 (IC50 = 1.03 ± 0.14 µM) more potently inhibited mushroom tyrosinase than kojic acid (IC50 = 25.26 ± 1.10 µM). Docking results showed 2 binds strongly to the active site of tyrosinase, while 3 binds strongly to an allosteric site. Kinetic studies using l-tyrosine as substrate indicated 2 and 3 competitively and non-competitively inhibit tyrosinase, respectively, which was supported by our docking results. In B16F10 cells, 3 significantly and concentration-dependently reduced α–MSH plus IBMX induced increases in cellular tyrosinase activity and melanin production and the similarity between these inhibitory patterns implied that the anti-melanogenic effect of 3 might be due to its tyrosinase-inhibitory ability. In addition, 2 and 3 exhibited strong antioxidant effects; for example, they reduced ROS and ONOO– levels and exhibited radical scavenging activities, suggesting that these effects might underlie their anti-melanogenic effects. Furthermore, 3 suppressed the expressions of melanogenesis-associated proteins and genes in B16F10 cells. These results suggest (Z)-5-(substituted benzylidene)-3-cyclohexyl-2-thioxothiazolidin-4-one analogs offer a means of producing novel anti-melanogenesis agents.